Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Silo Pharma, Inc. (SILO)

2.5628   -0.017 (-0.67%) 01-27 15:36
Open: 2.52 Pre. Close: 2.58
High: 2.595 Low: 2.52
Volume: 15,494 Market Cap: 8(M)

Technical analysis

as of: 2023-01-27 4:47:57 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 5.78     One year: 7.66
Support: Support1: 2.34    Support2: 1.95
Resistance: Resistance1: 4.95    Resistance2: 6.55
Pivot: 2.71
Moving Average: MA(5): 2.57     MA(20): 2.79
MA(100): 4.23     MA(250): 6.33
MACD: MACD(12,26): -0.2     Signal(9): -0.2
Stochastic oscillator: %K(14,3): 21.5     %D(3): 19.5
RSI: RSI(14): 38.9
52-week: High: 12.44  Low: 0.17
Average Vol(K): 3-Month: 445 (K)  10-Days: 25 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ SILO ] has closed above bottom band by 22.7%. Bollinger Bands are 82.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 58 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.6 - 2.61 2.61 - 2.63
Low: 2.48 - 2.5 2.5 - 2.52
Close: 2.54 - 2.57 2.57 - 2.59

Company Description

Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company focuses on merging traditional therapeutics with psychedelic research for patients with depression, post-traumatic stress disorder, Alzheimer's, Parkinson's, and other rare neurological disorders. It has a scientific research agreement with the University of Maryland, The Regents of the University of California, and Columbia University. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is headquartered in Englewood Cliffs, New Jersey.

Headline News

Sun, 29 Jan 2023
Farm Silos: Uses, Benefits, and Disadvantages - Krishi Jagran

Sun, 29 Jan 2023
The reveal of Quirindi’s Silo Art Project -

Sun, 29 Jan 2023
Quirindi silos interactive light show is officially open - The Northern Daily Leader

Fri, 27 Jan 2023
Fix Broken Customer Journeys: 5 Solutions to CX Silo Issues - CMSWire

Thu, 26 Jan 2023
Silo’s Charley Hampton signs with McLennan for softball - KXII

Tue, 24 Jan 2023
USAF to begin Minuteman III silo conversion to house Sentinel ICBM by decade's end - Breaking Defense

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  PNK
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. -1 (M)
Shares Float 0 (M)
% Held by Insiders 9.867e+007 (%)
% Held by Institutions 1.82e+006 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS 66260
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.03
Profit Margin (%) 5
Operating Margin (%) 594.7
Return on Assets (ttm) -3
Return on Equity (ttm) 526.8
Qtrly Rev. Growth 71.2
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio 0
PEG Ratio 0
Price to Book value 82.9
Price to Sales 0
Price to Cash Flow 0

Stock Dividends

Dividend 9930
Forward Dividend 0
Dividend Yield 386381%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.